Adisyn has cleared its first real graphene technical hurdle with independently verified low-temperature deposition that ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

Douglas County will soon be seeking applications for an advisory board to help give recommendations on how to preserve the ...

For the past 10 years, the Fresh Start program has helped mothers escape the clutches of addiction while being able to ...

From broad R&D to validated platforms, HPQ advances fumed silica, battery materials, and hydrogen while realigning capital ...

Kentucky is one of the most disaster-prone states, and disaster-stricken communities are finding themselves ill-equipped to ...

For the fifth time in December, Kansas City firefighters were called to the vacant Parade Park Homes complex near 18th and ...

At 4 a.m., while most of New Jersey slept, a Princeton Plasma Physics Laboratory (PPPL) physicist sat at his computer ...

Trial sponsors are typically responsible for providing the experimental drug or treatment at no cost to patients. However, ...

Kuwait: In a strategic step aimed at building a corporate culture founded on continued growth and improving operational ...

Officials and providers increasingly emphasized care delivered outside traditional hospitals and clinics — through mobile ...

KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...